Guides · Shock loss

Shock loss:
shedding after surgery.

Shock loss is temporary shedding of the hair around the transplanted area, typically beginning 2 to 8 weeks after surgery, with regrowth usually starting around 3 months. It is shedding of existing hair rather than loss of the grafts, and it is a recognised phase of recovery rather than a sign the procedure has failed. How often it happens depends enormously on who you are: one 621-patient series measured it in 3.7% of patients overall but 20.9% of the women, with female sex carrying an odds ratio of 30.18.

See the recovery timeline
What is actually known

Seven published figures. Two of them disagree with each other.

Reported as published, including the range that is too wide to be useful, because that width is the finding.

What Published value Source
When it starts Within 2–8 weeks of surgery Romera de Blas et al. 2026
When regrowth begins Usually around 3 months after surgery Romera de Blas et al. 2026
Reported incidence 0.15–15% across the literature Romera de Blas et al. 2026
Measured in one 621-patient series 3.7% of all patients; 20.9% of the women in the series Okochi et al. 2024
Dominant risk factor Female sex: odds ratio 30.18 (95% CI 9.43–96.55, p<0.001) Okochi et al. 2024
Additional risk in women Increasing age: odds ratio 1.07 per year (95% CI 1.00–1.15, p=0.039) Okochi et al. 2024
Technique-side risk factors High implantation density of 50–70 FU/cm², over-tumescence, psychological stress Romera de Blas et al. 2026
About that range

0.15% to 15% is a hundredfold spread.

A reported incidence spanning two orders of magnitude is not a number you can plan around, and it would be easy to quietly pick a point inside it. We are showing the range instead, because the width is itself the honest answer: studies define recipient-site effluvium differently, measure it at different intervals, and draw on populations with very different sex ratios, and sex turns out to move the risk by a factor of thirty. A clinic quoting you one confident percentage for shock loss is quoting a number the literature does not currently support.

The more useful framing is conditional. If you are a man having a frontal case at a moderate density, the published series puts this well below one in twenty. If you are a woman, particularly over forty with female pattern loss, the same series puts it above one in five, and that belongs in the conversation before you book rather than in a leaflet afterwards.

The part you can influence

Transplant density is also a risk factor.

Among the technique-side risk factors identified, the one worth arguing about at consultation is implantation density: 50 to 70 follicular units per cm² is listed alongside over-tumescence and stress as raising the risk. Dense packing is what gets sold, because density is what looks impressive in a plan. It is also what stresses the blood supply around existing follicles, which is the mechanism by which they shed. Asking for the maximum density a clinic will agree to is therefore not a free choice, and a clinic that treats it as one is not describing the trade-off honestly.

What this page will not tell you is what proportion of shed hair comes back. That figure is quoted constantly (usually as around ninety-five per cent), and we could not trace it to a primary source, so it does not appear here. See what results are realistic for the site's general position on outcome figures.

Timing, mechanism, incidence range and technique-side risk factors: Romera de Blas C, Vega Díez D, Ricart Vayá JM, Gómez Zubiaur A. Complications in follicular unit excision hair transplantation: current evidence and practical approaches. Frontiers in Medicine. 2026;13:1750989, doi:10.3389/fmed.2026.1750989 (https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1750989/full), measured 2026-07-28. Measured incidence, sex and age risk: Okochi H, Onda M, Momosawa A, Okochi M. An Analysis of Risk Factors of Recipient Site Temporary Effluvium After Follicular Unit Excision: A Single-Center Retrospective Study. Aesthetic Plastic Surgery. 2024;48:1258–1263, doi:10.1007/s00266-023-03699-z, PMID 37816944, 621 patients (554 men, 67 women) (https://pubmed.ncbi.nlm.nih.gov/37816944/), measured 2026-07-28.

FAQ

Common questions about shedding after surgery.

How common is shock loss after a hair transplant?
The published range is wide: a 2026 complications review reports incidence between 0.15% and 15%, and a 621-patient retrospective series measured it in 3.7% of patients overall. The variation is largely explained by sex. In that series it affected 20.9% of the women against a far lower rate in men, with female sex carrying an odds ratio of 30.18.
When does shock loss start and how long does it last?
It typically begins within 2 to 8 weeks of surgery, and regrowth usually starts around 3 months postoperatively. It is described in the literature as temporary shedding of hair around the implanted area rather than loss of the grafts themselves.
Does shock loss mean my transplant has failed?
No. Shock loss is shedding of existing hair around the treated area, driven by temporary disruption of the hair cycle from surgical trauma, perifollicular inflammation, local ischaemia or vasoconstrictive anaesthetic agents. It is a recognised, usually temporary phase. This site does not publish a figure for how much shed hair returns, because we could not source one.
Are women more likely to get shock loss?
Yes, substantially. In a 621-patient single-centre series, female sex was the dominant risk factor with an odds ratio of 30.18 (95% CI 9.43–96.55, p<0.001), and 20.9% of the women in that series experienced it. Increasing age raised the risk further among women, at an odds ratio of 1.07 per year.
Can shock loss be reduced?
The identified technique-side risk factors are high implantation density (50–70 follicular units per cm²), over-tumescence and psychological stress, which is an argument for a conservative density plan rather than the maximum a clinic will agree to. Management in the literature is primarily conservative (reassurance and expectation-setting), with topical or oral minoxidil noted as potentially accelerating regrowth. Discuss any medication with the operating clinic.

© 2026 Every Follicle Counts